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Abstract
Aspergillus fumigatusis a saprophytic fungus that is ubiquitous in the environment and commonly
associated with allergic sensitization and severe asthma in humans. Although A. fumigatus is
recognized by multiple microbial pattern recognition receptors, we identified and synthesized an
A. fumigatus glycosphingolipid, asperamide B, that directly activated invariant natural killer T
(iNKT) cells in vitro in a CD1d-restricted, MyD88- and dectin-1-independent fashion. Moreover,
asperamide B, when loaded into CD1d, directly stained, and was sufficient to activate, iNKT cells.
In vivo, asperamide B rapidly induced airway hyperreactivity, a cardinal feature of asthma, by
activating pulmonary iNKT cells in an IL-33-ST2-dependent fashion. Asperamide B is thus the
first fungal glycolipid found to directly activate iNKT cells. These results extend the range of
microorganisms that can be directly detected by iNKT cells to the Kingdom of Fungi, and may
explain the effectiveness of A. fumigatus in causing severe chronic respiratory diseases in humans.
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tIntroduction
Asthma is an inflammatory disease of the airways that affects 300 million individuals
worldwide. The inflammation in asthma is frequently driven by Th2 cells and adaptive
immunity against environmental aeroallergens. Although the allergen-specific Th2 cells that
mediate asthma recognize the protein components of allergens, most environmental
allergens contain a complex mixture of lipids and carbohydrates that might function as
adjuvants to enhance the process of sensitization. For example, house dust mite contains
ligands of TLR41 and dectin-22, which activate innate immune cells, including dendritic
cells (DCs), airway epithelial cells and macrophages, thereby enhancing the capacity of dust
mite to stimulate adaptive Th2 cell sensitization. However, other allergens, such as fungi,
may utilize additional immunological mechanisms to enhance sensitization.
The saprophytic fungus Aspergillus fumigatus contains several clinically important allergens
and is highly associated with allergic asthma. A. fumigatus spores or conidia are recovered at
very high rates from the environment, from within buildings and homes and in soil, resulting
in daily respiratory exposure in most individuals3, 4. Although A. fumigatus can cause
invasive infection, primarily in immunocompromised hosts with defects in neutrophil
function, in normal healthy individuals A. fumigatus conidia are rapidly cleared by
phagocytes after recognition through soluble and cell-associated microbial pattern
recognition receptors, including TLR2, TLR4, surfactant proteins A and D, C3, dectin-1 and
DC-SIGN5, 6. However, in some individuals, allergic sensitization to A. fumigatus develops.
In patients with asthma, allergic sensitization to A. fumigatus is associated with severe
disease with reduced lung function7, 8. Indeed, a syndrome called severe asthma with fungal
sensitization (SAFS), is often associated with A. fumigatus colonization of the lung9. Rarely,
particularly in patients with severe asthma or with cystic fibrosis, a unique hypersensitivity
response to A. fumigatus develops, known as allergic bronchopulmonary aspergillosis
(ABPA), associated with very high levels of serum IgE, eosinophilia, bronchiectasis,
pulmonary infiltrates and chronic severe asthma symptoms10. The precise mechanisms
however, for innate immune recognition of A. fumigatus that result in allergic sensitization
and asthma are not fully known.
We therefore examined an innate-like pathway that might be activated by A. fumigatus
involving invariant natural killer T (iNKT) cells. iNKT cells recognize glycolipid antigens
presented by CD1d, rapidly produce large quantities of cytokines, and are thought to play an
important role in regulating the development of airway hyperreactivity (AHR), a cardinal
feature of asthma11, although their role in human asthma is less clear12. iNKT cells express
an invariant T cell receptor (iTCR), which is highly conserved evolutionarily and thought to
serve as a receptor for pathogen associated molecular patterns. Up to now however, only a
few microbes have been shown to express glycolipid antigens that can be directly
recognized by the iTCR of iNKT cells. The high degree of conservation of the iNKT cell
iTCR across many mammalian species suggests that other types of microorganisms,
including fungi such as A. fumigatus, may also express glycolipids that can be recognized by
the iTCR of iNKT cells.
Albacker et al. Page 2
Nat Med. Author manuscript; available in PMC 2014 July 02.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tResults
An A. fumigatus extract rapidly induces airway hyperreactivity
Intranasal treatment of wildtype BALB/c mice for 3 days with A. fumigatus extracts resulted
in the development of severe AHR and airway inflammation 24 hrs after the last dose (Fig.
1a). Our protocol was significantly shorter than previous protocols with A. fumigatus, in
which mice were repeatedly challenged with A. fumigatus over 2-4 wks to induce potent
Th2-mediated adaptive immunity13-15. In our studies, the severe AHR and airway
inflammation in response to A. fumigatus extract occurred independently of adaptive
immunity, in mice deficient for MHC class II (H2.Ab1-Ea−/−), which lack class II restricted
CD4+ T cells, but which have iNKT cells (Fig. 1b, c). The induction of AHR by A.
fumigatus required IL-4 and IL-13, since it did not occur in Il4−/−Il13−/− mice (Fig. 1d).
Although Il4−/−Il13−/− mice failed to develop AHR, they developed airway neutrophilia
(Fig. 1e). mRNA for IL-4 andIL-13 but not IFN-γ was increased in the lungs after treatment
with A. fumigatus, as shown by analysis of total lung RNA by Q-PCR (Fig. 1f). These
results suggested that the A. fumigatus extract contained glycolipids that activated iNKT
cells.
Induction of AHR by A. fumigatus requires NKT cells
Indeed, the A. fumigatus extract failed to induce AHR in iNKT cell-deficient CD1d1−/−
mice, while causing severe AHR in wildtype mice (Fig. 2a). The recruitment of neutrophils
to the airway however, was independent of CD1d (Fig. 2b). These data suggest that the A.
fumigatus extract contains several activities, such that AHR was CD1d and IL-4/IL-13
dependent, while inflammation was CD1d and IL-4/IL-13 independent. The number of
iNKT cells in the BAL and lung increased after treatment with the A. fumigatus extract, as
determined by flow cytometry, particularly in the lung in terms of percent of TCRβ+ cells
and absolute number of iNKT cells (Fig. 2c–f). Moreover, Tcra-J18−/− mice, which like
CD1d1−/− mice lack iNKT cells, also failed to develop AHR (Fig.2g), but this response was
reconstituted by adoptive transfer of CD1d-tetramer-sorted wildtype iNKT cells (Fig.2g). To
control for the possibility that tetramer sorting could activate the transferred iNKT cells,
unsorted wildtype splenocytes were used to reconstitute Tcra-J18−/− mice with iNKT cells,
which also restored the AHR response to A. fumigatus (Supplemental Fig. 1). Combined,
these experiments showed that iNKT cells are required for the development of the acute
AHR in response to the A. fumigatus extract.
A. fumigatus-induced AHR requires MyD88 but not Ticam1 or dectin-1
Myd88−/− mice treated with the A. fumigatus extract developed a reduced AHR response,
and significantly reduced inflammatory response in the BAL fluid compared to wild-type
mice (Fig. 3a, b). Moreover, the Myd88−/− mice failed to respond when challenged
intranasally with only 1 dose (rather than 3 daily doses) of A. fumigatus extract and
evaluated 24 hrs later, in contrast to wildtype mice, which developed severe AHR and
airway inflammation (Fig. 3c, d). These findings suggested that A. fumigatus extract
contained glycolipids that rapidly induce AHR, but that this response required signaling
through TLR receptors or through the IL-1 receptor accessory protein (Il1Rap), a component
of the IL-1 and IL-33 receptors. In contrast, the A. fumigatus-induced AHR response did not
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trequire Ticam1, since Lps2/Lps2 mice, which have an early stop codon in the Ticam1 gene,
fully responded to three intranasal doses of A. fumigatus, as did wildtype mice (Fig. 3e, f). In
addition, the AHR response induced by the A. fumigatus extract was independent of
dectin-1, since treatment with a dectin-1 specific antibody (500 μg/mouse) did not reduce
AHR induced with the A. fumigatus extract (Fig. 3g), although the dectin-1 antibody
reduced the influx of neutrophils into the BAL fluid by 50% (Fig. 3h), and greatly reduced
the in vivo induction of IL-12 by the dectin-1 ligand, laminarin (β-1, 3- and β-1, 6 glucans
from seaweed Laminaria digitata)16 (Fig.3i).
A purified A. fumigatus lipid activates iNKT cells
We next examined A. fumigatus extract fractions for their capacity to activate primary iNKT
cell lines. A fraction that contained most of the activating activity was identified, from
which a single lipid compound with a molecular mass of 738 was isolated that migrated as a
single spot on high performance thin layer chromatography. Further characterization via
single and multidimensional NMR spectroscopy and mass spectrometry (manuscript in
preparation), revealed spectral data that matched those of a previously reported
glycosphingolipid called asperamide B. Asperamide B had previously been isolated from
culture extracts of Aspergillus niger, an endophytic fungus isolated from marine brown
alga17. Importantly, asperamide B, the structure of which is shown in Fig. 4a, was present in
significantly higher quantities in extracts from A. fumigatus than from A. niger (Fig. 4b, p <
0.001 student's t-test).
Coculture of BMDC and primary iNKT with purified asperamide B (pAsp-B) induced IL-4
and IFN-γ production in a dose dependent manner, with IL-4 reaching statistical significance
at the highest dose (Fig. 4c and Supplemental Fig. 2a). Furthermore, a synthetic version of
asperamide B (sAsp-B) (manuscript in preparation) also induced IL-4 and IFN-γ production
in iNKT cells in a dose dependent manner (Fig. 4d and Supplemental Fig. 2b). Activation of
iNKT cells by asperamide B required CD1d, since coculture with BMDC from CD1d1−/−
mice failed to induce IL-4 or IFN-γ (Fig. 4e and Supplemental Fig. 2c). Asperamide B most
likely directly activated iNKT cells, since the induction of IL-4 and IFN-γ production by
both the purified and synthetic asperamide B was MyD88 and Ticam1 independent, similar
to the response observed with the control PBS57 (α-GalCer analog) (Fig.4e). Although
previous studies showed that Aspergillus indirectly activated iNKT cells by stimulating
dectin-1 on APCs and inducing IL-12 production18, blockade with an anti-dectin-1 mAb had
no effect on iNKT cell activation by our Aspergillus extract or by sAsp-b (Fig. 4f), although
the anti-dectin-1 mAb greatly reduced the induction of IL-12 in BMDC by the dectin-1
ligand, laminarin (Fig. 4g). Furthermore, our Aspergillus allergen extract induced only small
amounts of IL-12 in BMDC (Fig. 4h), indicating that our Aspergillus allergen extract, in
contrast to other Aspergillus extracts18, contained little IL-12-inducing pathogen associated
molecular patterns (PAMPs, e.g. β-glucans). However, both the purified and synthetic
asperamide B also activated primary human iNKT cell lines to produce statistically
significant amounts of IL-4 and IL-13 (Fig.4i, j). These in vitro results suggested that A.
fumigatus might drive respiratory disease in mice and in humans in part through direct
effects of asperamide B on iNKT cells.
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tAsperamide B loaded CD1d tetramers bind to iNKT cells
We loaded CD1d tetramers with the sAsp-B glycolipid, and found that it stained splenic
iNKT cells, similar to the staining observed with PBS57 loaded tetramers (known to stain all
iNKT cells) (Fig. 5a). The percentage of CD4+ cells and the Vβ distribution of the sAsp-B
and PBS57 tetramer+iNKT cells were also similar, as about 85% of both sAsp-B+ and
PBS57+iNKT cells were CD4+, and about 50% were Vβ8.1/2+ (Fig. 5b, c). However, small
differences were noted in the number of sAsp-B+ and PBS57+iNKT cells that stained with
anti-Vβ7 (13.8% for sAsp-B and 11.5% for PBS57) and anti-Vβ2 mAb (9.8% of sAsp-B and
8.2% of PBS57). The staining results with sAsp-B and PBS57 loaded CD1d tetramers,
including the similar Vβ distributions of the stained cells, were confirmed by staining
primary iNKT cell lines (Supplemental Fig. 3a–c). Incubation of iNKT cell lines
simultaneously with both tetramers resulted in staining only with PBS57 loaded tetramers
(Supplemental Fig. 3d), suggesting that both tetramers could bind the same iTCRs.
Moreover, plate bound sAsp-B loaded, but not unloaded, CD1d monomers effectively
activated primary iNKT cell lines (Fig. 5d). The effect of the plate bound CD1d monomers
on the iNKT cell lines was amplified when a CD28 activating antibody was added to these
cultures (Fig. 5e). These results together indicate that the sAsp-B and PBS57 CD1d
tetramers stain similar populations of iNKT cells, and that asperamide B can be directly
recognized by the iTCR of iNKT cells.
Asperamide B induces AHR in vivo in wildtype mice
A single dose of purified asparamide B administered to wildtype mice induced AHR within
24 hrs, although the asparamide B was less potent compared to PBS57 (Fig.5f). Asperamide
B also induced airway inflammation with a statistically significant increase in macrophages
and a small number of neutrophils that did not reach significance (Fig. 5g). The number of
lung iNKT cells producing IL-4 alone or IL-4 + IL-13 were significantly increased while the
increase in cells producing IL-13 alone did not reach statistical significance (Fig. 5h). These
numbers were calculated from data of the total number of iNKT cells in the lung and the
fraction of iNKT cells producing IL-4 and IL-13 (Supplemental Fig. 4a, b). The AHR and
the airway inflammatory response to asparamide B required the presence of iNKT cells,
since it failed to occur in CD1d1−/− mice (Fig. 5i), and also required IL-4 and IL-13, since it
failed to occur in Il4−/−Il13−/− mice (Fig. 5j and Supplemental Fig. 4c). These findings
indicate that asperamide B is a major component of A. fumigatus that can induce the
development of AHR and airway inflammation.
Role of IL-33 in asparamide B-induced AHR
Like the A. fumigatus extract, asparamide B failed to induce AHR in Myd88−/− mice after a
single dose (Fig.6a). However, asperamide B required IL-33R/ST2 signaling, since Il1rl1−/−
mice, which lack the receptor for IL-33, failed to respond to asperamide B (Fig. 6b).
Il1rl1−/− mice showed normal populations of iNKT cells compared to WT mice, ruling out a
deficiency in iNKT cells as a cause for the absence of AHR in Il1rl1−/− mice (Supplemental
Fig. 5). We therefore hypothesized that asperamide B-induced AHR requires MyD88,
because Il1Rap, a subunit of the IL-33 receptor, requires MyD88 for signaling. Indeed,
IL-33 mRNA was greatly increased in the lungs of mice within 3 hrs of administration of
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tasperamide B (Fig. 6c). In addition, asperamide B induced IL-33 production in several cell
types, including alveolar and interstitial macrophages (Fig. 6d). The induction of IL-33 in
alveolar macrophages appeared to be iNKT cell dependent, since iNKT cells cultured with
alveolar macrophages and asperamide B resulted in a significant increase in IL-33 mRNA in
the cultures (Fig. 6e). These results indicate that A. fumigatus contains a glycolipid antigen
that activates iNKT cells, which can induce alveolar macrophages and other APCs to
produce IL-33, which in turn is required for the development of AHR. In addition, these
results together indicate that asperamide B directly activates iNKT cells, and that the in vivo
requirement for MyD88 in the AHR response to A. fumigatus reflects the need for ST2
signaling through the Il1Rap.
Discussion
In these studies, we describe the identification of a fungal glycosphingolipid antigen,
asperamide B, that directly activated iNKT cells in a CD1d-restricted, MyD88-independent
manner. To our knowledge, this is the first report of a fungal glycolipid antigen that directly
activates both mouse and human iNKT cells, and therefore these studies very significantly
extend the range of microorganisms that are known to directly activate iNKT cells.
Moreover, we demonstrated that purified as well as synthesized asperamide B, by activating
iNKT cells, rapidly induced AHR, a cardinal feature of asthma, in the absence of adaptive
immunity, and that asperamide B, when loaded into CD1d, could directly stain and activate
iNKT cells. Because A. fumigatus is ubiquitous in the environment and is frequently
recovered from the respiratory tract, our observations are clinically important and help to
explain the potency of A. fumigatus in causing respiratory disease and severe asthma in
humans.
The number of distinct microorganisms known to activate iNKT cells has grown rapidly
over the past several years, but no previous study has found fungal glycolipid antigens that
directly activate iNKT cells19. Initially, iNKT cells were thought to react primarily to Gram
negative bacteria that lack LPS (e.g., Sphingomonas species)20, 21. However, subsequent
studies demonstrated that iNKT cells recognized lipids from several additional bacterial
species, including Borrelia burgdorferi22, Helicobacter pylori23, Streptococcus pneumoniae
and Group B Streptococcus24. Our results showing that glycolipids from A. fumigatus
directly activate iNKT cells extend the range of microorganisms that are directly detected by
iNKT cells into another biological Kingdom, i.e., Fungi. Therefore, the ability of the semi-
invariant TCR of iNKT to function as a pattern recognition receptor that recognizes both
pathogenic bacteria and fungi may explain the extensive conservation of this iTCR in most
mammalian species25.
Previous studies have suggested that although some microbial glycolipids can directly
activate iNKT cells, the dominant pathway for iNKT cell activation during microbial
infection involves the indirect pathway, in which iNKT cells respond secondarily to IL-12
produced by APCs activated by microbial PAMPs binding to pattern recognition receptors
(PRR)26. In particular, A. fumigatus express β-1, 3 glucans18, 27, 28, which trigger dectin-1
and induce the production of IL-12, which then secondarily activates iNKT cells18.
However, A. fumigatus causes several different types of pathologies, including invasive
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ttissue disease, but also hypersensitivity disease and asthma. While the indirect, IL-12-
dependent pathway for iNKT cell activation may be critically important during invasive
aspergillosis29, it may be less relevant for Aspergillus hypersensitivity disease occurring at
mucosal surfaces30. In this mucosal response, asperamide B may directly activate iNKT
cells, triggering the production of IL-13 and IL-33, independently of dectin-1 and IL-12.
Thus, these distinct pathways may be differentially engaged depending on the setting (e.g.,
in the airways versus in the tissues), although it is possible that the β-glucan/dectin-1 and the
asperamide B pathways may overlap and synergize in some conditions, such as chronic
fungal exposure31, 32.
The A. fumigatus glycolipid identified in our studies, asperamide B, which could activate
both mouse and human iNKT cells, stimulated mouse iNKT cells in vitro in a MyD88-
independent manner. In contrast, the in vivo induction of AHR by the A. fumigatus
glycolipid required MyD88, presumably because the induction of AHR by asperamide B
also required IL-33 and its receptor, ST2. Signaling through ST2requires MyD88, since the
IL-33 receptor heterodimeric complex includes both ST2 (IL-1 receptor-like 1, Il1rl1) and
the Il1Rap, which recruits and utilizes the TIR binding adaptor protein, MyD88. In the
lungs, we propose that asperamide B activates iNKT cells, which then trigger APCs such as
alveolar macrophages to produce IL-33. A similar induction of IL-33 in alveolar
macrophages by iNKT cells was recently described with α-Galactosylceramide and
Sphingomonas glycolipids in the lungs33, and in hepatocytes by iNKT cells in the liver34.
After being secreted in the lungs, IL-33 can activate a subset of IL-33 responsive iNKT
cells35 and type 2 innate lymphoid (ILC2) cells (also called, nuocytes or natural helper
cells35-40), both of which can produce IL-13 and induce AHR.
The induction of IL-33 synthesis in macrophages by asperamide B-activated iNKT cells
may also help to explain the robust capacity of A. fumigatus to induce AHR. IL-33 is an
innate cytokine that has been shown to potently cause AHR in the absence of adaptive
immunity33, 39, 41. Notably, since only some glycolipids that activate iNKT cells induce
AHR, the ability of asperamide B to induce IL-33 production may be an important
characteristic that distinguishes it from other glyoclipids that cannot induce AHR. We
hypothesize that alveolar macrophages take up only some iNKT cell activating glycolipids,
but these allow an interaction with iNKT cells and the production of IL-33, which then
induces AHR. This IL-33-ST2 axis may be critical for the development of AHR, and is very
distinct from the indirect iNKT cell activation pathway, which involves IL-12 and IFN-
γ18, 27, 28 and clearance of infection. Thus, the specific glycolipid and APC with its
associated cytokines together shape the response after iNKT cell activation, and may help to
explain how iNKT cells selectively regulate distinct forms of immunity.
Moreover, because A. fumigatus is ubiquitous in the environment, respiratory exposure to A.
fumigatus is common, and recognition of asperamide B by iNKT cells in some individuals
may critically translate A. fumigatus exposure into significant respiratory disease. Although
only 2-3% of individuals in the general population develop allergic sensitization to A.
fumigatus (as determined by immediate skin test positivity)42, 43, in asthma, approximately
28% of patients including 45% of patients with severe asthma, develop A. fumigatus
sensitization9, 44. The high rate of sensitization to A. fumigatus in severe chronic asthma
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the hyphae, which contain the asperamide B lipid. We therefore propose that the direct
activation of iNKT cells by asperamide B from A. fumigatus at the mucosal surface in the
lungs may drive the development of allergic sensitization to Aspergillus and to AHR,
particularly in patients with severe asthma11, 45.
Although iNKT cells may have evolved to rapidly respond to pathogenic microorganisms,
their capacity when activated to serve as an adjuvant for Th2-type immunity has been
previously suggested, for example, in response to environmental glycolipids from plant
pollens46, in house dust47 and cow's milk48, 49. Thus, in patients with allergic disease and
asthma, it is possible that glycolipids from A. fumigatus, cypress tree pollen, cow's milk and
Sphingomonas species (which are often found in the lungs of patients with poorly controlled
asthma50) all activate iNKT cells, which then provide potent adjuvant activity to enhance
allergic, Th2 adaptive sensitization to accompanying proteins. The environment may thus be
replete with such iNKT cell activating compounds that are recognized and sensed by iNKT
cells and that may enhance allergic sensitization51. As such, iNKT cells, which may be
increased in number in the mucosa of allergy prone children52, may play a critical role in
allergy and allergic asthma. This idea is also consistent with the observation that most
protein allergens have lipid binding activity53, 54, which may allow glycolipids that activate
iNKT cells to associate with these clinically important protein allergens, facilitating Th2
sensitization.
Methods
Animals
Wild-type BALB/cByJ, C57Bl/6J, H2.Ab1-Ea−/−, and Lps2/Lps2 were obtained from
Jackson Laboratory, Bar Harbor, ME. Dr. M. Grusby, Harvard School of Public Health,
provided CD1d1−/− mice, backcrossed to the BALB/c strain. Drs. M. Taniguchi, and T.
Nakayama, Chiba University generously provided Tcra-J18−/− mice. The Myd88−/− strain
was generated by S. Akira, and backcrossed to the BALB/c strain by Dr. R. Geha, Boston
Children's Hospital, who provided breeding pairs to us. Dr. A. McKenzie, Medical Research
Council, Laboratory of Molecular Biology, Cambridge, U.K, generated the Il4−/−Il13−/− and
Il1rl1−/− mice. Female mice were studied at approximately 6-8 weeks of age and were age
matched. The Animal Care and Use Committee, Children's Hospital Boston approved all
animal protocols.
Aspergillus fumigatus administration and airway hyperreactivity
An Aspergillus fumigatus fungal extract was obtained from the NIH research reagent
program. Mice lightly anesthetized with isoflurane were given 100 μg of A. fumigatus by the
intranasal route on three consecutive days. In some experiments only one dose of the A.
fumigatus extract was given. In other experiments, purified or synthesized glycolipids
suspended in vehicle (containing BSA, Tween20 and histadine) were administered
intranasally to mice. One day after the final dose, mice were sedated, tracheostomized, and
ventilated. Direct measurement of airway resistance and dynamic compliance was
performed by invasive plethysmogrophy (BUXCO systems). Two pressure sensors measure
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tchange in lung volume and change in tracheal pressure. From these measurements, average
lung resistance was calculated for three minutes per dose of methacholine55. After
measurement of airway hyperreactivity, bronchoalveolar lavage was performed by flushing
the airways twice with 1 ml phosphate buffered saline. Cells were then counted on a
standard hemocytometer and centrifuged onto glass slides. Brochoalveolar lavage cells were
then stained by DiffQuick, a modified Mae-Wright-Giemsa stain. Numbers of macrophages,
eosinophils, neutrophils, and lymphocytes were assessed by cell morphology.
Flow cytometry
Alternatively, iNKT cells from the bronchoalveloar lavage were stained with the following
antibodies/reagents CD11b-FITC, CD19-FITC, PBS57 loaded or control unloaded CD1d
tetramers-PE (NIH, NIAID MHC tetramer core facility), CD45-PE-Texas Red, TCRβ-
eFluor780, CD4-Alexa700. Macrophages were identified using CD45-PE-Texas Red, F4/80-
FITC, and CD11c-eFluor780. All samples were blocked with 1 μg Fc block for 15 minutes
prior to antibody/tetramer staining at 4C for 30 minutes in phosphate buffered saline
containing 2% fetal calf serum (2% FCS-PBS). Cells were washed twice in 2% FCS-PBS
and then data was collected on a FACSCanto (BD Biosciences). Analysis of FACS plots
was performed using FlowJo (Treestar).
For intracellular staining, after fixation and permeabilization (Cytofix/Cytoperm kit; BD
Biosciences), iNKT cells were incubated with anti-13-APC and anti-IL-4-FITC, while
macrophages were incubated with anti–IL-33-PE. The respective isotype control was used
for each experiment.
CD1d tetramer loading
To generate sAspB loaded mCD1d monomers, 30 × molar excess of sAspB in DMSO at 5
mg/ml was incubated with biotinylated-mCD1d (from the NIH Tetramer facility) in 4 mM
CHAPS and 20 mM Tris pH7.0 overnight at room temperature with slight agitation. The
mCD1d monomers were tetramerized by adding SA-PE (S868, Invitrogen) to the lipid-
loaded monomers as previous described56.
Plate bound CD1d tetramer assay
Streptavidin plates (96-well) were incubated with 0.5 μg of CD1d monomer overnight.
Plates were washed with PBS and incubated overnight with lipid in CHAPS/Tris buffer (see
tetramer loading). Plates were washed with PBS and then cultured with 5 × 105 iNKT cells
for 48hrs. In some wells, 5 μg/ml anti-CD28 mAb was added. Supernatants were assayed for
IL-4 and IFN-γ by ELISA.
Aspergillus glycolipid antigen purification
Aspergillus niger and Aspergillus fumigatus strains were grown in growth medium.
Mycelium was collected and lyophilized. Equal dry weight of both the strains were collected
and extracted in similar manner. Folch extraction was performed and LC-MS was carried
out on Folch's lower layer. Aspergillus fumigatus mycelia were extracted in 2:1
CHCl3:MeOH three times. All of the extracts were pooled and dried. Liquid-liquid
extraction according to Folch's procedure was performed to remove highly polar
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tcontaminants. The folch lower layer was dried and subjected to silica gel column
chromatography. The crude glycolipid fraction was further purified by acylation and de-
acylation protocols to yield pure compound. 1H and 2D NMRs and ESI-MS/CID-/MS
techniques were used for structure determination. The glycolipid was identified as β-
glycosylceramide having (4E, 8E)-9-methyl-4, 8-sphingadienine as long chain base and
N-2′-hydroxy-(E)-3′-octadecenoate as an acid moiety (Chaudhary et al, manuscript in
preparation).
Quantitative PCR
To measure RNA expression, lung tissue was pooled and homogenized in TRIzol reagent
and total lung RNA was purified according to the manufacturer's instructions. Quantitative
PCR was performed on an ABI7300 using Applied Biosystem primers and probes for the
indicated genes in triplicate wells. Gene expression was normalized using GAPDH. Delta
cycle time (d-ct) for the gene of interest was calculated by subtracting the ct of GAPDH
from the ct of the gene of interest. dd-ct was calculated by subtracting the treated d-ct from
the control d-ct. Fold change is calculated as 2dd-ct. Standard deviation for dd-ct was
calculated using the standard square root of squares method. Error bars in the figure are
calculated as 2dd-ct + s.d.(dd-ct). Statistical analysis was calculated on normalized d-ct values
between treated and control groups with an n=3.
iNKT cell lines
Mouse and human iNKT cells lines were generated and maintained in our laboratory as
previously described39, 57. iNKT cells (5 × 104) were cocultured with GM-CSF treated bone
marrow derived DCs (104) and the indicated glycolipids for 48 hrs. Supernatants were
assessed for IL-4 and IFN-γ by ELISA.
Statistical tests
Data from in vivo experiments are presented as mean ± s.e.m., while data from in vitro
experiments (iNKT/BMDC cocultures) are presented as mean ± s.d. Data were analyzed by
ANOVA or unpaired student's t test using Prism 4 (GraphPad Software Inc.).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. An A. fumigatus extract rapidly induces AHR independent of adaptive immunity
(a-e). Meaurement of airway hyperreactivity (AHR) and differenatial cell count of
bronchoalveolar lavage (BAL) after treatment with three 100 μg intranasal doses of an A.
fumigatus extract. (mean ± s.e.m., * p < 0.05, ** p < 0.01, *** p < 0.001 Two-Way
ANOVA, Bonferoni post-test). (a) AHR of wild-type BALB/c mice. Pooled data of three
experiments are shown (saline n= 11, A.f. n = 13). (b) AHR and (c) BAL count of mice
deficient for MHC class II (H2.Ab1-Ea−/−) and C57BL/6 mice as control. Pooled data of two
experiments are shown (WT n = 5, MHCII−/− Saline n = 7, A.f. n = 8). (d) AHR and (e)
BAL count of Il4−/−Il13−/− double knockout mice and BALB/c as control. Pooled data of
three experiments are shown. (n = 9). (f) Quantification of mRNA expression by QPCR in
the lungs of A. fumigatus treated mice. Fold induction of A. fumigatus treated over saline
treated mice is shown (mean ± s.d., *** p < 0.001, Two-way ANOVA, Bonferoni post-test)
One representative experiment of five is shown.
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tFigure 2. AHR induced by A. fumigatus extract is dependent on iNKT cells
(a) Measurement of AHR and (b) BAL cell count in CD1d1−/− and BALB/c treated with
three intranasal 100 μg doses of A. fumigatus extract. Pooled data from two experiments are
shown (WT n = 7, CD1d1−/− n = 6), (mean ± s.e.m., * p < 0.05, ** p < 0.01, *** p < 0.001,
Two-Way ANOVA, Bonferoni post-test). (c-f)(c) BAL or (d) lung cells from saline or A.
fumigatus treated mice were analyzed by FACS for iNKT cells. PBS57 (α-GalCer analogue)
loaded CD1d tetramer and TCRβ staining identify iNKT cells with unloaded tetramer as a
control. Number shows % of CD45+ lymphocytes falling within the iNKT gate. One
representative mouse of three is shown. The absolute number of iNKT in the (e) BAL or (f)
lung is shown (mean ± s.e.m., * p < 0.05, *** p < 0.001, student's t-test). (g) AHR of
Tcra.J18−/− mice that received 106 PBS57-CD1d tetramer sorted iNKT cells from the spleen
of wild-type mice treated with intranasal A. fumigatus extract. One representative
experiment of three is shown (n=4, *** p < 0.001 Two-Way ANOVA, Bonferoni post-test).
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tFigure 3. AHR induced with A. fumigatus extract is dependent on MyD88 but not Ticam1
(a-h). Meaurement of airway hyperreactivity (AHR) and differenatial cell count of
bronchoalveolar lavage (BAL) after treatment with the indicated number of 100 μg
intranasal doses of an A. fumigatus extract. (mean ± s.e.m., * p < 0.05, ** p < 0.01, *** p <
0.001 Two-Way ANOVA, Bonferoni post-test). (a) AHR and (b) BAL count of Myd88−/−
and BALB/c mice administered three doses. Pooled data from three experiments is shown
(WT n=9, Myd88−/− saline n=8, A.f. n=10). (c) AHR and (d) BAL count of Myd88−/− and
BALB/c mice administered one dose. Representative data from one of two experiments are
shown (n=4). (e) AHR and (f) BAL count of mice deficient for Ticam1 (Lps2/Lps2) and
C57BL/6 mice as control. Pooled data from two experiments is shown (WT n = 7, Lps2 n =
6). (g) AHR and (h) BAL count of BALB/c mice that were administered an antibody to
Dectin-1 or isotype control (500 μg/mouse), and intranasal A. fumigatus extract (n=5). (i)
Measurement of serum IL-12 by ELISA after treatment with 100 mg Laminarin. An
antibody to Dectin-1 or isotype control (500 μg/mouse) was administered 12 h prior (*** p <
0.001, student's t-test).
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tFigure 4. Purified and synthetic asperamide B activate mouse and human iNKT cells
(a) Structure of isolated Aspergillus fumigatus lipid, asperamide B, with a molecular weight
of 738. (b) Asperamide B peak area in a liquid chromatography-mass spectometry
chromatogram is shown for A. fumigatus and A. niger (*** p < 0.001, student's t-test). (c-f)
Measurement of IL-4 at 48 hours in coculture supernatants of 5 × 104 iNKT and 104 BMDC
treated with the indicated lipids (mean ± s.d.). (c) Cocultures treated with DMSO (D),
purified asperamide B (pAsp-B), or PBS57 (α-GalCer analogue). (d) Cocultures treated with
DMSO (D), synthetic asperamide B (sAsp-B), and PBS57. (c-d) * p < 0.05, ** p < 0.01,
One-Way ANOVA, Dunnett's Multiple Comparison Test to DMSO Control. (e) Cocultures
with BMDC from BALB/c, CD1d1−/−, Myd88−/− or Ticam1−/− treated with the indicated
lipids (** p < 0.01, *** p < 0.001, Two-Way ANOVA, Bonferoni post-test). (f) Cocultures
were incubated with an antibody specific for Dectin-1 (2 μg ml−1) and treated with vehicle,
A. fumigatus extract, sAsp-B, or PBS57. (g) Measurement of IL-12 by ELISA at 24 hours in
BMDC cultures treated with laminarin (500 μg ml−1) with or without anti-dectin-1 mAb (2
μg ml−1), (** p < 0.01, student's t-test). (h) Measurement of IL-12 by ELISA at 24 hours in
BMDC cultures treated with A. fumigatus extract or laminarin at the indicated
concentrations. (i-j) Measurement of (i) IL-4 and (j) IL-13 by ELISA at 48 hours in
cocultures of primary human iNKT cell lines and APCs treated with DMSO, pAspB, sAspB,
or PBS57. (* p< 0.05, *** p < 0.001, student's t-test compared to DMSO control) (a–j)
mean ± s.d.
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tFigure 5. Asperamide B loaded CD1d stains and directly activates iNKT cells
(a) FACS plots showing spleen cells stained for CD3 and CD1d tetramers loaded with
vehicle (left panel), sAsp-B (middle panel) or PBS57 (right panel). (b-c) FACS plots
showing CD4 and Vβ usage by (b) sAsp-B tetramer+ cells and (c) PBS57 tetramer+ cells. (d)
Cytokine production from iNKT cells cultured on plates coated with CD1d monomers
loaded with sAsp-B (300 μg ml−1) or no lipid. (e) iNKT stimulated with plate bound CD1d
loaded with sAsp-B plus 5 μg ml−1CD28 antibody. (d-e) * p < 0.05, ** p < 0.01, student's t-
test. (f) Measurement of AHR and (g) BAL cell count in BALB/c treated with a single
intranasal dose of vehicle (n = 9), 5 μg of pAsp-B (n = 8), or 1 μg of PBS57 (n = 9). Pooled
data from three experiments are shown. (h) Measurement of IL-4 and IL-13 secreting by
iNKT cells in mice treated with vehicle, pAsp-B, or PBS57. (f-h) mean ± s.e.m., ns p > 0.05,
* p < 0.05, ** p < 0.01, *** p < 0.001, Two-Way ANOVA, Bonferoni post-test (i-j)
Measurement of AHR in (i)CD1d1−/− or (j)Il4−/−Il13−/− mice treated with 5 μg of pAsp-B
or vehicle. BALB/c control is the same in i and j, (WT n ≥ 19, CD1d1−/− n ≥ 7, Il4−/−Il13−/−
n ≥ 6). Pooled data from four experiments are shown.
Albacker et al. Page 18
Nat Med. Author manuscript; available in PMC 2014 July 02.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 6. Asperamide B-induced AHR requires MyD88 and ST2
(a-b) Measurement of AHR after treatment with a single intranasal dose of 5 μg of pAsp-B
or vehicle (mean ± s.e.m., ** p < 0.01, *** p < 0.001, Two-Way ANOVA, Bonferoni post-
test). (a) AHR measured in Myd88−/− and BALB/c control mice (WT n = 4, Myd88−/− n = 5)
treated with pAsp-B. Representative data from one of two experiments are shown. (b) AHR
measured in Il1rl1−/− (ST2) and BALB/c control mice (WT n = 7, Il1rl1−/− n = 6). Pooled
data of two experiments are shown. (c) IL-33 mRNA measured by QPCR from mice treated
with pAsp-B. Fold induction of IL-33 mRNA compared to the zero time-point is shown.
One representative experiment of two is shown (mean ± s.e.m., *** p < 0.001 One-Way
ANOVA, Tukey's multiple comparison post-test). (d) The number of IL-33+ lung
macrophages following treatment with vehicle, 5 μg of pAsp-B, or 1 μg of PBS57. Alveolar
macrophages were defined as F4/80+CD11c+ and interstitial macrophages were defined as
F4/80+CD11c−. One representative experiment of two is shown (mean ± s.e.m., * p < 0.05,
** p < 0.01, Two-Way ANOVA, Bonferoni post-test). (e) IL-33 mRNA was measured by
QPCR after 24 hours from cocultures of iNKT cells with alveolar macrophages incubated
with DMSO, pAsp-B, or PBS57 (mean ± s.d., *** p < 0.001, student's t-test).
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